Blog


  • 2019
  • 2018
  • 2017
  • 2016

Raymond N. Barto

Federal Grand Jury Validates Allegations in In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation

Posted by Raymond N. Barto on 04/22/2019

A federal grand jury indicted Indivior Inc. and Indivior PLC for fraudulently marketing its blockbuster drug, Suboxone. The indictment echoed the same allegations made by plaintiffs in In re: Suboxone (Buprenorphine Hydrochloride and Naloxone) Antitrust Litigation, No. 2:13-md-02445, a civil case that plaintiffs have been litigating in the ...

Read more

Patrick J. Collopy

Walmart Employees Win $6 Million Judgement in Meal Break Lawsuit

Posted by Patrick J. Collopy on 04/22/2019

On April 12, 2019, a California federal jury awarded $6 million to Walmart workers at a Chino, California warehouse who worked as "Associates" as far back as June 8, 2013. During meal breaks, Walmart required Associates to go through a lengthy "asset protection" process that included an anti-theft metal detector checkpoint if they wished to ...

Read more

Innessa M. Huot

U.S. House of Representatives Passes Paycheck Fairness Act to Attack Gender Pay Gap

Posted by Innessa M. Huot on 04/22/2019

The United States House of Representatives passed the proposed Paycheck Fairness Act (the "Bill") to rid employees of sex-based pay differentials and make wage practices more transparent. The Bill adds several layers of procedural protections to the Equal Pay Act of 1963 ("EPA") and requires employers to prove that any wage discrepancies are ...

Read more

Patrick J. Collopy

DOL Proposes New Rule for Overtime Eligibility

Posted by Patrick J. Collopy on 03/12/2019

On March 07, 2019, the United States Department of Labor ("DOL") proposed to increase the salary threshold required for executive, administrative and professional ("EAP") workers to qualify as exempt from overtime under the Fair Labor Standards Act ("FLSA"). Once finalized, the DOL rule will convert more than one million workers – earning ...

Read more

Joshua Nassir

Faruqi & Faruqi Defeats Motion to Dismiss In Consumer Class Action Challenging Bayer’s Flintstones Complete Multivitamin Gummies

Posted by Joshua Nassir on 03/08/2019

On March 6, 2019, Judge John A. Kronstadt of the Central District of California denied Bayer's motion to dismiss plaintiff's complaint in its entirety. The Court declined to dismiss plaintiff's allegations that defendants mislead consumers into believing their Flintstones Complete Children's Multivitamin Gummies products contain a complete ...

Read more

Joshua Nassir

Geographical Origin Consumer Cases On The Rise

Posted by Joshua Nassir on 03/06/2019

When shopping for everyday items, it's not only what's inside the package that counts. Consumers care about the product's background, and rightfully so. It comes as no surprise that geographical origin lawsuits for consumer products are becoming increasingly common. Just recently, on February 27, 2019, a collection of Kona, Hawaii coffee growers ...

Read more

Dillon Hagius

Federal Judge Reverses Decision in Blockchain ICO Case

Posted by Dillon Hagius on 02/25/2019

Judge Gonzalo Curiel of the Southern District of California has reversed his recent decision to deny the Securities and Exchange Commission's ("SEC") motion for a preliminary injunction against Blockvest's Initial Coin Offering ("ICO"). In an order dated February 14, 2019, Judge Curiel granted the SEC's motion to reconsider his earlier decision. ...

Read more

Dillon Hagius

Faruqi and Faruqi Clients Object to Synergy Pharmaceuticals’ Bankruptcy Plan on Behalf of Putative Shareholder Class  

Posted by Dillon Hagius on 02/25/2019

On February 21, 2019, co-lead plaintiffs of a putative Synergy Pharmaceuticals shareholder class objected to Synergy Pharmaceuticals' Chapter 11 Bankruptcy Plan. The objection was made before Judge James L. Garrity in the United States District Court for the Southern District of New York. It states, inter alia, that the Plan would improperly ...

Read more

Kristyn Fields

Defendants’ Motion for Stay Denied in Lamictal Pay-For-Delay Case

Posted by Kristyn Fields on 02/22/2019

On February 15, 2019, Magistrate Judge Cathy L. Waldor issued a text order denying defendants GlaxoSmithKline PLC and Teva Pharmaceutical Industries Ltd.'s motion to stay the district court proceedings pending resolution of their Rule 23(f) petition to review the Court's order certifying the direct purchaser class. GSK and Teva petitioned ...

Read more

Faruqi & Faruqi

Faruqi & Faruqi, on Behalf of Direct Purchasers, Defeats Motion to Dismiss in Zetia Pay-For-Delay Case

Posted by Faruqi & Faruqi on 02/20/2019

On February 6, 2019, Magistrate Judge Douglas E. Miller of the Eastern District of Virginia recommended that the district court deny defendants Merck & Co., Inc. and Glenmark Pharmaceuticals Inc.'s motion to dismiss in the pay-for-delay case over Merck's blockbuster cholesterol drug Zetia. Faruqi & Faruqi represent the direct purchaser plaintiffs ...

Read more

Finding us

Our Offices


Our offices are nationwide. If you have any questions about a case or our firm, please contact us.

New York

685 Third Avenue 26th Floor
New York, New York 10017
(212) 983-9330
(877) 247-4292
(212) 983-9331

California

10866 Wilshire Boulevard Suite 1470
Los Angeles, California 90024
(424) 256-2884
(424) 256-2885

Delaware

3828 Kennett Pike Suite 201
Wilmington, Delaware 19807
(302) 482-3182
(302) 482-3612

Georgia

3975 Roswell Rd Suite A
Atlanta, Georgia 30342
(404) 847-0617
(404) 506-9534

Pennsylvania

1617 JFK Boulevard, Suite 1550
Philadelphia, Pennsylvania 19103
(215) 277-5770
(215) 277-5771

Faruqi & Faruqi office in New York, New York

Faruqi & Faruqi office in Los Angeles, California

Faruqi & Faruqi office in Wilmington, Delaware

Faruqi & Faruqi office in Atlanta, Georgia

Faruqi & Faruqi office in Philadelphia, Pennsylvania